Unlock instant, AI-driven research and patent intelligence for your innovation.

Nucleic acid for encoding human NADH dehydrogenase subunit 4 protein and application thereof

A dehydrogenase subunit and nucleic acid technology is applied to nucleic acid encoding human NADH dehydrogenase subunit 4 protein and its application field, and can solve the problem of low transfection efficiency and poor therapeutic effect of NADH dehydrogenase subunit 4 protein. and other problems, to achieve the effect of good hereditary optic neuropathy and high transfection efficiency

Active Publication Date: 2020-04-28
WUHAN NEUROPHTH BIOTECHNOLOGY LTD CO
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The technical problem to be solved in the present invention is to overcome the technical defects of low transfection efficiency and poor therapeutic effect of NADH dehydrogenase subunit 4 protein in the prior art, and provide a targeted NADH dehydrogenase subunit 4 protein And its preparation method and application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nucleic acid for encoding human NADH dehydrogenase subunit 4 protein and application thereof
  • Nucleic acid for encoding human NADH dehydrogenase subunit 4 protein and application thereof
  • Nucleic acid for encoding human NADH dehydrogenase subunit 4 protein and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Construction of Example 1 Plasmid and Preparation of Recombinant Adeno-Associated Virus

[0045] 1.1 Plasmid preparation: After obtaining the human ND4 nucleotide sequence (National Center for Biotechnology Information Reference Sequence: yp_003024035.1), the present invention optimizes the coding sequence of COX10 (as shown in SEQ ID NO: 2) and changes the mitochondria The ND4 nucleotide sequence is a nuclear coding sequence and is optimized (as shown in SEQ ID NO: 1, referred to as optimizing ND4 gene / nucleic acid in the present invention), the homology of optimized COX10+ND4 and unoptimized COX10+ND4 sequences Sex is 76.16%. And the UTR sequence (as shown in SEQ ID NO: 4) is connected to the 3' end of the optimized ND4 gene, and the sequence of its fusion gene (or fusion nucleic acid) is shown in SEQ ID NO: 5, provided by Chengdu Qingke Zixi Biotechnology Ltd Synthetics. The full-length gene was amplified by PCR ( figure 2 ), through EcoRI / SalI digestion to form ...

Embodiment 2

[0053] Example 2 rAAV2 Infection 293T Experiment

[0054] Resuscitate frozen 293T cells and carry out subculture, grow to about 90% of the T75 culture flask, digest the cells with trypsin, take the cell pellet, and resuspend the cells with DMEM complete medium at a density of 5×10 4 individual / mL. Cells were planted in a 96-well plate, and 100 μL of cell suspension was added to each well, about 5000 cells / well. 37°C, 5% CO 2 Cultivate in the environment until the cells are overgrown to about 50% of the well plate, according to MOI=10 4 Add virus liquid rAAV2-ND4-EGFP and rAAV2-optimized ND4-EGFP (2×10 10 vg / 0.02uL) and 0.02uL PBS, after 48h, the fluorescent microscope observation, RT-PCR detection and immunoblotting were performed.

[0055] After 48 h, the fluorescence microscope observation was carried out as follows: image 3 , Fluorescence photography showed that EGFP was successfully expressed, indicating that rAAV was used as the carrier, and the EGFP gene transfecte...

Embodiment 3

[0056] Example 3 Experiment of Intravitreal Injection of rAAV2 in Rabbit Eyes

[0057] 12 rabbits were divided into 3 groups equally, and the virus liquid rAAV2-ND4 and rAAV2-optimized ND4 (1×10 10 vg / 0.05mL) and PBS were punctured into the pars plana of the ciliary body 3mm away from the limbus into the vitreous cavity. After the vitreous cavity injection, slit lamp, fundus photographic examination and HE staining were performed. After 30 days of injection, each group underwent RT respectively. - PCR detection and immunoblotting.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
refractive indexaaaaaaaaaa
Login to View More

Abstract

The invention discloses a nucleic acid for encoding human NADH dehydrogenase subunit 4 protein. The nucleotide sequence of the nucleic acid is shown as SEQ ID NO: 1. The invention also discloses a fusion nucleic acid which comprises the nucleic acid for encoding the human NADH dehydrogenase subunit 4 protein. The invention further discloses a recombinant expression vector which comprises the nucleic acid or the fusion nucleic acid. Also disclosed is a transformant into which the aforementioned nucleic acid or fusion nucleic acid is introduced in a host. The invention also discloses a preparation method of the human NADH dehydrogenase subunit 4 protein. The preparation method comprises the following steps: (1) obtaining the transformant; and (2) screening the transformant, and expressing and purifying the human NADH dehydrogenase subunit 4 protein. The nucleic acid expression quantity of the encoded human NADH dehydrogenase subunit 4 protein is higher, so that more human NADH dehydrogenase subunit 4 proteins can be obtained in mitochondria, and Leber hereditary optic neuropathy can be better treated.

Description

technical field [0001] The invention relates to the field of biological preparations, in particular to nucleic acid encoding human NADH dehydrogenase subunit 4 protein and application thereof. Background technique [0002] Leber hereditary optic neuropathy (LHON) is a degenerative vision disorder that usually presents with bilateral loss of central vision. The average age of onset is in the mid-20s, and there is usually no pain for several weeks to months until the binocular vision deteriorates below 0.1, seriously affecting the quality of life of the patient. LHON is caused by mutations in mitochondrial genes associated with mutations in one of the three mitochondrial genes for NADH ubiquinone oxidoreductase, the complex I subunit of the mitochondrial respiratory chain. Studies have shown that the G3460A mutation affecting the ND1 gene, the T14484C mutation affecting the ND6 gene, and the G11778A mutation affecting the ND4 gene are believed to be the main causes of LHON, a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/53C12N9/02C12N15/62C12N15/85C12N5/10
CPCC07K2319/00C12N9/0036C12N15/85C12Y106/99003A61K48/00C12N5/10C12N15/62
Inventor 李斌
Owner WUHAN NEUROPHTH BIOTECHNOLOGY LTD CO